A recent report published by Infinium Global Research on post operative nausea and vomiting market provides in-depth analysis of segments and sub-segments in the global as well as regional post operative nausea and vomiting market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional post operative nausea and vomiting market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global post operative nausea and vomiting market. According to the report, the global post operative nausea and vomiting market is projected to grow at a CAGR of 8.38% over the forecast period of 2021-2027.

Market Insight

The global post operative nausea and vomiting market size to grow from USD 1.92 billion in 2020 to USD 3.32 billion by 2027, at a CAGR of 8.4% during the forecast period. Post operative nausea and vomiting are uncomfortable for patients and can lead to more serious complications. It is an enormous problem for patients recovering after surgery. About 30% of people experience vomiting and 50% experience nausea. As many as 80% of high-risk individuals may experience post operative nausea and vomiting.

Post operative nausea and vomiting (PONV) are amongst the most frequently occurring complications in patients undergoing surgery with general anesthesia. Nausea and vomiting is a common and distressing symptom or side effect in medicine, surgery and following anesthesia. Generally, uncomplicated PONV rarely goes beyond 24 hours post-operatively and problematic PONV however is more multifactorial in origin and can be difficult to treat effectively. Patients at risk of this should be identified by the anesthetist and may be given prophylactic anti-emetic treatment. Post operative nausea and vomiting (PONV) are one of the complex and significant problems in anesthesia practice, with the growing trend toward ambulatory and daycare surgeries. A growing adoption rate of combination therapies as well as non-pharmacological treatment modes is driving the growth of the market. Moreover, the surge in funding is expected to boost the growth of post operative nausea and vomiting (PONV) during the forecast period. However, strict regulatory approvals and high health care expenditure is affecting the growth of the market during the forecast period. Moreover, the launch of newer therapies is anticipated to provide a significant growth opportunity for the market.

Asia Pacific holds the largest market shares in the Post-operative Nausea and Vomiting (PONV) Market. A growing number of patients undergoing surgical procedures and an increase in compliance to pharmacologic and non-pharmacologic treatments are attributing to the growth of the market in this region. Furthermore, a large presence of local pharmaceutical companies in this region is expected to propel market growth in the Asia Pacific region. Moreover, North America is expected to grow with a healthy CAGR. The healthcare remuneration in the United States of America (USA) has transitioned from volume-based systems to value-based systems. This means healthcare institutions are financially incentivized to provide care according to evidence-based best practices.

Segment Covered

The report on global post operative nausea and vomiting market covers segments such as treatment type, and distribution channel. On the basis of treatment type, the sub-markets include serotonin antagonists, dopamine antagonists, NK-1 receptor antagonists, and non-pharmacological treatment. On the basis of distribution channel, the sub-markets include hospital pharmacies, and retail pharmacies & drug stores.

Companies Profiled:

The report provides profiles of the companies in the market such as Novartis AG, Acacia Pharma, Hoffmann-La Roche AG, Camurus AB, Sanofi S.A, Helsinn Holding S.A, Eisai Corporation, Merck and Co, and GlaxoSmithKline Corporation.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of post operative nausea and vomiting market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.